Xianhong Yin

Dr. Xianhong Yin

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2019 in Clinical Hypertension
Verified
Journal Article
Open access
PDF file
LALi Anle
Li Anle
XFXiang Fang
Xiang Fang
YZYi-Ying Zhang
Yi-Ying Zhang
QPQian Peng
Qian Peng
XYXianhong Yin
Xianhong Yin
To explore the familial aggregation and heritability of hypertension in Han in Shanghai China. According to l:l matched pairs design, 342 patients of hypertension and 342 controls were selected and investigate their nuclear family members in the case-control study. The method of genetic epidemiology research was used to explore the familial aggregation and heritability of hypertension. The prevalence rate of hypertension of first-degree relatives was significantly higher (34.44%) than that of second- degree relatives (17.60%) and third-degree relatives (13.51%) in Han Population in Shanghai China. Separation ratio p was 0.217, and prevalence rate of case group relatives was higher than that of control group relatives. The results showed a phenomenon of familial aggregation in the distribution of hypertension. The heritability of first- degree relatives was 49.51%; that of second-degree relatives and third-degree relatives were respectively 23.42 and 21.41%. The distribution of essential hypertension has phenomenon of familial aggregation in Han Population in Shanghai China. The separation ratio of essential hypertension in this study shows that essential hypertension conform to the characteristics of multigene genetic disease. The heritability of first-degree relatives is bigger than that of second-degree relatives and third-degree relatives.

3 March 2020 in medRxiv
Verified
Preprint
Open access
PDF file
YLYi Li
Yi Li
MLMeng Liang
Meng Liang
XYXianhong Yin
Xianhong Yin
XLXiaoyu Liu
Xiaoyu Liu
MHMeng Hao
Meng Hao
LJLi Jin
Li Jin
Summary: Background: In December 2019, pneumonia infected with a novel coronavirus burst in Wuhan, China. Now the situation is almost controlled in China but is worse outside China. We aimed to build a mathematical model to capture the global trend of epidemics outside China. Methods: In this retrospective, outside-China diagnosis number reported from Jan 21 to Feb 28, 2020 was downloaded from WHO website. We develop a simple regression model on these numbers: where N t is the total diagnosed patient till the i th day, t=1 at Feb 1. Findings: Based on this model, we estimate that there have been about 34 unobserved founder patients at the beginning of spread outside China. The global trend is approximately exponential, with the rate of 10 folds every 19 days. Research in context: Evidence before this study: In December 2019, pneumonia infected with a novel coronavirus burst in Wuhan, China. Now the situation is almost controlled in China but is worse outside China. Now there are 4,691 patients across 51 countries and territories outside China. We searched PubMed and the China National Knowledge Infrastructure database for articles published up to Feb 28, 2020, using the keywords “COVID”, “novel coronavirus”, “2019-nCoV” or “2019 novel coronavirus”. No published work about the global trend of epidemics outside China could be identified. Added value of this study: We built a simple “log-plus” linear model to capture the global trend of epidemics outside China. We estimate that there have been about 34 unobserved founder patients at the beginning of spread outside China. The global trend is approximately exponential, with the rate of 10 folds every 19 days. Implications of all the available evidence: With the limited number of data points and the complexity of the real situation, a straightforward model is expected to work better. Our model suggests that the COVID-19 disease follows an approximate exponential growth model stably at the very beginning. We predict that the number of confirmed patients outside China will increase ten folds in every 19 days without strong intervention by applying our model. Powerful actions on public health should be taken to combat this epidemic all over the world.

23 February 2020 in medRxiv
Verified
Preprint
Open access
PDF file
YLYi Li
Yi Li
XYXianhong Yin
Xianhong Yin
MLMeng Liang
Meng Liang
XLXiaoyu Liu
Xiaoyu Liu
MHMeng Hao
Meng Hao
YWYi Wang
Yi Wang
Importance: To predict the diagnosed COVID-19 patients and the trend of the epidemic in China. It may give the public some scientific information to ease the fear of the epidemic. Objective: In December 2019, pneumonia infected with the novel coronavirus burst in Wuhan, China. We aimed to use a mathematical model to predict number of diagnosed patients in future to ease anxiety on the emergent situation. Design: According to all diagnosis number from WHO website and combining with the transmission mode of infectious diseases, the mathematical model was fitted to predict future trend of outbreak. Setting: Our model was based on the epidemic situation in China, which could provide referential significance for disease prediction in other countries, and provide clues for prevention and intervention of relevant health authorities. Participants: In this retrospective, all diagnosis number from Jan 21 to Feb 10, 2020 reported from China was included and downloaded from WHO website. Main Outcome(s) and Measure(s): We develop a simple but accurate formula to predict the next day diagnosis number: ,where N i is the total diagnosed patient till the i th day, and α was estimated as 0.904 at Feb 10. Results: Based on this model, it is predicted that the rate of disease infection will decrease exponentially. The total number of infected people is limited; thus, the disease will have limited impact. However, new diagnosis will last to March. Conclusions and Relevance: Through the establishment of our model, we can better predict the trend of the epidemic in China.

6 May 2026 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
BLBaihao Lin
Baihao Lin
HDHao Deng
Hao Deng
YWYingjun Wu
Yingjun Wu
XNXiang Nie
Xiang Nie
XJXinqi Jiang
Xinqi Jiang
XYXianhong Yin
Xianhong Yin

9 October 2026 in Science China Life Sciences
Verified
Journal Article
Closed access
PDF file
YWYifei Wang
Yifei Wang
YZYuyu Zheng
Yuyu Zheng
HCHaifang Chen
Haifang Chen
HDHao Deng
Hao Deng
YYYujia Yang
Yujia Yang
XYXianhong Yin
Xianhong Yin

31 August 2026 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
HLHui Luo
Hui Luo
XWXueting Wang
Xueting Wang
CZCheng Zhang
Cheng Zhang
JHJing He
Jing He
MSMengjie Sun
Mengjie Sun
XYXianhong Yin
Xianhong Yin
Background: Insulin resistance (IR) is a key driver of cardiovascular–kidney–metabolic (CKM) syndrome. This study evaluated the independent associations of three novel IR surrogate indices—the Metabolic Score for Insulin Resistance (METS–IR), Triglyceride–Glucose–Body Mass Index (TyG–BMI), and Single Point Insulin Sensitivity Estimator (SPISE)—with CKM syndrome risk and compared their predictive performance for short- and long-term outcomes. Methods: This retrospective cohort study included 12,334 Chinese adults aged ≥20 years enrolled between 2015 and 2019. Multivariable logistic regression and restricted cubic splines were used for association assessment, while area under the receiver operating characteristic curve (AUROC) analysis was used to evaluate predictive accuracy. Subgroup analyses were performed for age, sex, and BMI. Results: Analysis of 1- and 5-year follow-up outcomes revealed that the METS–IR and TyG–BMI were positively associated with CKM syndrome, whereas SPISE showed an inverse association (all p < 0.001). All indices exhibited nonlinear dose–response relationships. Adding each IR index separately to the base model improved discrimination: 1-year AUROC increased from 0.681 to 0.710–0.712 and 5-year AUROC from 0.719 to 0.737–0.741 (all p < 0.001). SPISE achieved the highest AUROC at both time points, pairwise comparisons with the other indices showed statistically significant differences of 0.002–0.003 (all p ≤ 0.033). Subgroup analyses indicated stronger associations in males and participants aged <40 years for short-term risk, with sex-specific effect modification for long-term outcomes. Conclusion: The METS-IR, TyG-BMI, and SPISE showed robust nonlinear associations with CKM syndrome risk. Their overall discriminatory performance was broadly comparable, with SPISE showing a marginal advantage. The associations were stronger in males, supporting their potential value in sex-tailored risk assessment.